NICE guidance on cancer drug

Healthcare Market News (News) May 2000 The National Institute for Clinical Excellence (NICE) has issued its guidance on the use of Taxanes in the treatment of ovarian cancer. The guidance recommends that the drug paclitaxel (Taxol) should be used to treat women with ovarian cancer as a standard initial therapy. It also recommends that paclitaxel…

You must be a HM Subscriber to view this content.

Subscribe Now »